Holoclara
We develop novel therapeutics derived from symbiotic organisms that modulate inflammation, metabolism, and tissue regeneration- core pathways that underlie chronic disease, resilience, and aging.
$16M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@Holoclara_Inc · created Jun 2, 2022 (4 years old) · 26 followers
Website registeredJan 23, 2017 (9 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $16M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
AC
Andrea Choe CEO / CO-FOUNDERLinkedIn · source: holoclara.com
Companies like Holoclara
VVandria$30.7M Series A · Aug 2024FFibroheal$1.47M Seed · Jul 2026
LLifeCyte Innovations$1M Seed · Aug 2026
GGranite Bio$30M Series A · Apr 2025
EExcalipoint TherapeticsSeed · Mar 2026
AAurenar$5.7M Seed · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/holoclara (get a free API key).